Understanding outcomes of advanced diabetic eye disease
Real-world outcomes of proliferative diabetic retinopathy
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11085212
This study is looking at how well treatments work for people with proliferative diabetic retinopathy (PDR), a serious eye condition that can cause blindness, by using health records to find patients at risk and improve their care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11085212 on ClinicalTrials.gov |
What this research studies
This research investigates the real-world outcomes of proliferative diabetic retinopathy (PDR), a severe form of diabetic eye disease that can lead to blindness. It aims to improve patient care by using electronic health records (EHRs) to identify patients at risk for PDR and to evaluate the effectiveness of treatments in a real-world setting. The study will develop automated methods to classify patients and predict disease progression, ultimately seeking to enhance treatment outcomes for those affected by PDR.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults with diabetes who are at risk for or currently have proliferative diabetic retinopathy.
Not a fit: Patients without diabetes or those who do not have any form of diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for patients at risk of vision loss from diabetic retinopathy.
How similar studies have performed: Previous research has shown promise in using electronic health records to improve patient outcomes in various conditions, suggesting this approach could be effective for PDR as well.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SUN, CATHERINE QING — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: SUN, CATHERINE QING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.